Evaluation of Council Regulation (EC) 953/2003 to avoid trade diversion into the European Union of certain key medicines | Tenderlake

Evaluation of Council Regulation (EC) 953/2003 to avoid trade diversion into the European Union of certain key medicines

Contract Value:
EUR 150K - 150K
Notice Type:
Contract award notice
Published Date:
19 December 2014
Closing Date:
Location(s):
BE BELGIQUE-BELGIË (BE Belgium/BELGIQUE-BELGIË)
Description:

The objectives of the current project, which is tendered by DG Trade, are to evaluate the Regulation on 4 points in line with the Commission's evaluation standards:

1. effectiveness: to what extent did the Regulation achieve its goals?

2. efficiency: were the costs involved justified, given the achievements? This includes in particular an assessment of administrative burden for businesses, especially SMEs;

3. coherence: to what extent is the Regulation coherent internally, with other EU policies, with Treaty objectives, and with the activities of other actors?

4. relevance: to what extent do the (original) objectives (still) correspond to the EU needs? What is the role of a Regulation?

Awarded to:
Evaluation of Council Regulation (EC) 953/2003 to avoid trade diversion into the European Union of certain key medicines
CRA International (UK) Ltd, London (UK)
Download full details as .pdf
The Buyer:
European Commission, Directorate-General for Trade, Directorate C — Asia and Latin America
CPV Code(s):
79419000 - Evaluation consultancy services